Extracellular vesicles: A new therapeutic strategy for joint conditions

Biochem Pharmacol. 2018 Jul:153:134-146. doi: 10.1016/j.bcp.2018.02.004. Epub 2018 Feb 7.

Abstract

Extracellular vesicles (EVs) are attracting increasing interest since they might represent a more convenient therapeutic tool with respect to their cells of origin. In the last years much time and effort have been expended to determine the biological properties of EVs from mesenchymal stem cells (MSCs) and other sources. The immunoregulatory, anti-inflammatory and regenerative properties of MSC EVs have been demonstrated in in vitro studies and animal models of rheumatoid arthritis or osteoarthritis. This cell-free approach has been proposed as a possible better alternative to MSC therapy in autoimmune conditions and tissue regeneration. In addition, EVs show great potential as biomarkers of disease or delivery systems for active molecules. The standardization of isolation and characterization methods is a key step for the development of EV research. A better understanding of EV mechanisms of action and efficacy is required to establish the potential therapeutic applications of this new approach in joint conditions.

Keywords: Extracellular vesicles; Immunomodulation; Inflammation; Mesenchymal stem cells; Osteoarthritis; Rheumatoid arthritis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / metabolism
  • Arthritis, Rheumatoid / therapy
  • Extracellular Vesicles / metabolism
  • Extracellular Vesicles / transplantation*
  • Humans
  • Immunity, Cellular / physiology
  • Joint Diseases / immunology
  • Joint Diseases / metabolism
  • Joint Diseases / therapy*
  • Mesenchymal Stem Cell Transplantation / methods
  • Mesenchymal Stem Cell Transplantation / trends
  • Mesenchymal Stem Cells* / immunology
  • Mesenchymal Stem Cells* / metabolism
  • Osteoarthritis / immunology
  • Osteoarthritis / metabolism
  • Osteoarthritis / therapy